# Ropinirole in the Treatment of Bipolar Depression

> **NCT00314821** · PHASE4 · COMPLETED · sponsor: **Cambridge Health Alliance** · enrollment: 40 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** ropinirole

## Key facts

- **NCT ID:** NCT00314821
- **Lead sponsor:** Cambridge Health Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-06-01
- **Final completion:** 2008-03-17
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314821, "Ropinirole in the Treatment of Bipolar Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00314821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*